High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study

JOURNAL ARTICLE published July 2020 in Breast Cancer

Authors: Yasuo Miyoshi | Yuta Yoshimura | Kenichi Saito | Kenzo Muramoto | Michiko Sugawara | Karenza Alexis | Kenichi Nomoto | Seigo Nakamura | Toshiaki Saeki | Junichiro Watanabe | Jose Manuel Perez-Garcia | Javier Cortes